ARTICLE | Clinical News
Dusquetide regulatory update
December 14, 2016 11:05 PM UTC
The U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) granted promising innovative medicine (PIM) designation to dusquetide from Soligenix to treat severe oral mucositis in head and ne...
BCIQ Company Profiles
BCIQ Target Profiles